Talking Rheumatology Research

Ep 25. How does symptom duration before DMARD therapy impact the costs of RA?

British Society for Rheumatology Episode 25

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 11:01

Dr Ilfita Sahbudin (University of Birmingham, UK) joins Dr Ai Lyn Tan to discuss the relationship between symptom/disease duration and resource utilisation/costs following rheumatoid arthritis diagnosis.

Want to read the full paper? Find it here

Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn

Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice